These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7568380)

  • 1. The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies.
    Yu DC; Huang SC; Barrio JR; Phelps ME
    Phys Med Biol; 1995 Jul; 40(7):1243-54. PubMed ID: 7568380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
    Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies.
    Yu DC; Huang SC; Grafton ST; Melega WP; Barrio JR; Mazziotta JC; Phelps ME
    J Nucl Med; 1993 Apr; 34(4):679-88. PubMed ID: 8455088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDOPA kinetics in brain tumors.
    Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
    J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates.
    Shoghi-Jadid K; Huang SC; Stout DB; Yee RE; Yeh EL; Farahani KF; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1134-48. PubMed ID: 10908046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal 18F-dopa uptake: absence of an aging effect.
    Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
    Rousset OG; Deep P; Kuwabara H; Evans AC; Gjedde AH; Cumming P
    Synapse; 2000 Aug; 37(2):81-9. PubMed ID: 10881028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
    Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
    Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling approach for separating blood time-activity curves in positron emission tomographic studies.
    Huang SC; Barrio JR; Yu DC; Chen B; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
    Phys Med Biol; 1991 Jun; 36(6):749-61. PubMed ID: 1908103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P; Léger GC; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma L-[18F]6-fluorodopa input function: a simplified method.
    Chan GL; Morrison KS; Holden JE; Ruth TJ
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):881-4. PubMed ID: 1506454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
    Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
    DeJesus OT; Haaparanta M; Solin O; Nickles RJ
    Brain Res; 2000 Sep; 877(1):31-6. PubMed ID: 10980240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight into the analysis of 6-[18F]fluoro-L-DOPA PET dynamic data in brain tissue without an irreversible compartment: comparative study of the Patlak and Logan analyses.
    Kawatsu S; Kato T; Nagano-Saito A; Hatano K; Ito K; Ishigaki T
    Radiat Med; 2003; 21(1):47-54. PubMed ID: 12801143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies arising from recent FDOPA articles.
    Cumming P; Gjedde A; Reith J
    J Nucl Med; 1997 Aug; 38(8):1267-71. PubMed ID: 9255163
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
    Cumming P; Ase A; Diksic M; Harrison J; Jolly D; Kuwabara H; Laliberté C; Gjedde A
    Biochem Pharmacol; 1995 Sep; 50(7):943-6. PubMed ID: 7575677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.